McKinney, Texas — September 23, 2026 — PharmFormulatorLLC today announced the official launch of PharmFormulator™, asubscription-based data platform designed to provide researchers,pharmaceutical scientists, pharmacists, and medical professionals withextensive, searchable access to ophthalmic drug product formulationestimates—including inactive ingredient concentrations typically absent frompublicly available labeling.
PharmFormulator is a source-linkedresearch platform with over 1,200 U.S. ophthalmic drug-product records,including label-derived information, non-validated analytical compositionestimates, and public patent research references designed to supportpreliminary generic research, formulation optimization, and comparative productanalysis.
“Pharmaceuticalinnovation is often slowed by incomplete access to formulation data,” said AlanL. Weiner, Ph.D., Managing Partner and Chief Executive Officer ofPharmFormulator LLC. “With PharmFormulator, we are providing a powerful,structured dataset that goes beyond labeling to deliver the level of detailscientists need to accelerate development and make better-informed decisions.While our listed formulas are not validated by analytical testing, they arebuilt using the closest approximated data from patents and other public sources.We believe having these concentration estimates more readily accessible to the scientificcommunity at low cost can dramatically help jump-start drug product formulationresearch efforts.”
A New Standard for FormulationTransparency
Unlike traditional drug databases thatfocus primarily on active ingredients and high-level excipient listings,PharmFormulator delivers:
- Quantitative estimated inactive ingredient concentrations derived from curated sources including regulatory filings, patents, literature, and analytical reconstructions
- Multi-parameter search capabilities, allowing users to simultaneously filter by product characteristics such as excipient name or function, pH range, and osmolality or by attributes such as brand name, manufacturer, selected NDC-related records, and FDA application number
- Side-by-side estimated formulation comparisons across branded and generic ophthalmic products
- Source-linked documentation, enabling traceability of formulation data
The platform’s intuitive interface enablesusers to rapidly identify formulations meeting specific criteria—for example,filtering products containing a viscosity agent and preservative within adefined pH and osmolality range—then drilling down into individual productrecords and associated source documentation.
Designed for Pharmaceutical R&D,Competitive Intelligence, and Public Access
PharmFormulator is built to serve a broadrange of stakeholders across the pharmaceutical and healthcare ecosystem,including:
- Formulation and CMC scientists conducting early-stage research for ophthalmic products
- Generic developers reviewing potential reference products or comparators
- Pharmaceutical companies needing competitive intelligence
- Pharmacists evaluating product distinctions
- Ophthalmologists and medical professionals assessing the basis for product characteristics
- Attorneys scoping out patent landscapes and strategies
- Executives and investors assessing risks, market precedents and differentiation
- General public knowledge on eye medications
By consolidating fragmented data into astructured, searchable environment, the platform has potential to reducetrial-and-error iterations and subsequently truncate both development time and associatedcosts. The Company has leveraged AI-developed tools for regular updating of thedatabase information as well as to position it for future capability expansionsof the website.
Subscription-Based Access
PharmFormulator is available viaindividual or multi-seat subscription tiers and offers a cost-effective optionfor 3 months without long-term commitment. The standard annual rate is offeredat a substantially discounted rate from the 3-month subscription rate. As well,PharmFormulator is SSO/SCIM configured for Enterprise subscriptions.
About PharmFormulator LLC
PharmFormulator is a specializedophthalmic scientific intelligence platform designed to accelerate preliminarydrug research and development for pharmaceutical professionals. By aggregatingpublic regulatory records, patent disclosures, official product labeling, andFDA filings, PharmFormulator provides a searchable library of ophthalmicformulation profiles and source-linked ingredient data.
The platform delivers analytical compositionestimates and source-reported ingredient profiles to help research teamsde-risk early-stage development, evaluate historical product records, and gainactionable market insights. PharmFormulator is an independent research toolintended strictly for preliminary reference and informational use; it does notprovide manufacturing, compounding, or clinical instructions, nor does itguarantee final product compositions or grant regulatory, legal, orfreedom-to-operate clearances.
For more information, visit https://PharmFormulator.com
Media Contact-PharmFormulator LLC:
Alan Weiner, Ph.D.
CEO/ManagingPartner
214-551-3152